glp-1 drugs mounjaro Eli Lilly launches weight loss drug in India at Rs 3,500 per 2.5mg dose Inside Mounjaro: The Biology Behind

GIPR agonists In contrast to the results inferred from the obesity-promoting effects of GIP, it has been shown that transgenic mice overexpressing GIP exhibit a significant decrease in weight gain after ingestion of an HFD, suggesting that chronic elevation of GIP levels well above physiological concentrations may exert a centrally mediated suppressive effect on appetite [124]

Is microdosing GLP-1s safe

While preclinical evidence demonstrates both peptide and antibody GIPR antagonists drive modest weight loss in rodents on their own ( 20% weight loss in DIO mice)

Mice were acclimatized in the procedure room for 7 days before the experiments

This means the final product is not reviewed for safety or efficacy the way commercial drugs are

[DOI] [PubMed] [Google Scholar] 38.Rowlands J., et al